{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:20:26Z","timestamp":1790011226847,"version":"4.0.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T00:00:00Z","timestamp":1349654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The impact of glucocorticoids (GC) on skeletal development has not been established. The objective of this study was to examine changes in volumetric bone mineral density (vBMD) and cortical structure over 1 year in childhood nephrotic syndrome (NS) and to identify associations with concurrent GC exposure and growth. Fifty-six NS participants, aged 5 to 21 years, were enrolled a median of 4.3 (0.5 to 8.1) years after diagnosis. Tibia peripheral quantitative computed tomography (pQCT) scans were obtained at enrollment and 6 and 12 months later. Sex, race, and age-specific Z-scores were generated for trabecular vBMD (TrabBMD-Z), cortical vBMD (CortBMD-Z), and cortical area (CortArea-Z) based on &amp;gt;650 reference participants. CortArea-Z was further adjusted for tibia length-for-age Z-score. Quasi-least squares regression was used to identify determinants of changes in pQCT Z-scores. At enrollment, mean TrabBMD-Z (\u22120.54\u2009\u00b1\u20091.32) was significantly lower (p\u2009=\u20090.0001) and CortBMD-Z (0.73\u2009\u00b1\u20091.16, p\u2009&amp;lt;\u20090.0001) and CortArea-Z (0.27\u2009\u00b1\u20090.91, p\u2009=\u20090.03) significantly greater in NS versus reference participants, as previously described. Forty-eight (86%) participants were treated with GC over the study interval (median dose 0.29\u2009mg\/kg\/day). On average, TrabBMD-Z and CortBMD-Z did not change significantly over the study interval; however, CortArea-Z decreased (p\u2009=\u20090.003). Greater GC dose (p\u2009&amp;lt;\u20090.001), lesser increases in tibia length (p\u2009&amp;lt;\u20090.001), and lesser increases in CortArea-Z (p\u2009=\u20090.003) were independently associated with greater increases in CortBMD-Z. Greater increases in tibia length were associated with greater declines in CortArea-Z (p\u2009&amp;lt;\u20090.01); this association was absent in reference participants (interaction p\u2009&amp;lt;\u20090.02). In conclusion, GC therapy was associated with increases in CortBMD-Z, potentially related to suppressed bone formation and greater secondary mineralization. Conversely, greater growth and expansion of CortArea-Z (ie, new bone formation) were associated with declines in CortBMD-Z. Greater linear growth was associated with impaired expansion of cortical area in NS. Studies are needed to determine the fracture implications of these findings. \u00a9 2013 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.1785","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T18:37:29Z","timestamp":1349721449000},"page":"480-488","source":"Crossref","is-referenced-by-count":43,"title":["Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome"],"prefix":"10.1093","volume":"28","author":[{"given":"Anne","family":"Tsampalieros","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Emory University Hospital, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R","family":"Denburg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Shults","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette S","family":"Zemel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sogol","family":"Mostoufi-Moab","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J","family":"Wetzsteon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M","family":"Herskovitz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista M","family":"Whitehead","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B","family":"Leonard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Pediatrics, Children's Hospital of Philadelphia, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,8]]},"reference":[{"issue":"4","key":"2024020318430938100_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1210\/jc.2009-1913","article-title":"Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults","volume":"95","author":"Leonard","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2024020318430938100_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","article-title":"The science and therapy of glucocorticoid-induced bone loss","volume":"27","author":"Lane","year":"1998","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"10","key":"2024020318430938100_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int."},{"issue":"4","key":"2024020318430938100_bib4","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology."},{"issue":"8","key":"2024020318430938100_bib5","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"J Clin Invest."},{"issue":"6","key":"2024020318430938100_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02093714","article-title":"The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies","volume":"150","author":"Brodehl","year":"1991","journal-title":"Eur J Pediatr."},{"issue":"3","key":"2024020318430938100_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.081101","article-title":"Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome","volume":"24","author":"Wetzsteon","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2024020318430938100_bib8","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1210\/jc.2003-030432","article-title":"Cortical bone density is normal in prepubertal children with growth hormone (GH) deficiency, but initially decreases during GH replacement due to early bone remodeling","volume":"88","author":"Schweizer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024020318430938100_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children","volume":"98","author":"The primary nephrotic syndrome in children","year":"1981","journal-title":"J Pediatr."},{"issue":"2","key":"2024020318430938100_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics."},{"issue":"9","key":"2024020318430938100_bib11","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/jbmr.427","article-title":"Volumetric bone mineral density and bone structure in childhood chronic kidney disease","volume":"26","author":"Wetzsteon","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024020318430938100_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2008.09.072","article-title":"Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease","volume":"136","author":"Dubner","year":"2009","journal-title":"Gastroenterology."},{"issue":"4","key":"2024020318430938100_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1681\/ASN.2011050480","article-title":"Bone density and cortical structure after pediatric renal transplantation","volume":"23","author":"Terpstra","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"2024020318430938100_bib14","volume-title":"Assessment of skeletal maturity and prediction of adult height (TW2 method)","author":"Tanner","year":"1975"},{"issue":"3","key":"2024020318430938100_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02088471","article-title":"Validation of a self-administered instrument to assess stage of adolescent development","volume":"9","author":"Morris","year":"1980","journal-title":"J Youth Adolesc."},{"issue":"1","key":"2024020318430938100_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1385\/JCD:3:1:009","article-title":"pQCT measurement of bone parameters in young children: validation of technique","volume":"3","author":"Binkley","year":"2000","journal-title":"J Clin Densitom."},{"issue":"4","key":"2024020318430938100_bib17","doi-asserted-by":"crossref","first-page":"W284","DOI":"10.2214\/AJR.10.4247","article-title":"Muscle edema","volume":"194","author":"McMahon","year":"2010","journal-title":"AJR Am J Roentgenol."},{"key":"2024020318430938100_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0076-6879(97)82106-4","article-title":"Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers","volume":"282","author":"Hollis","year":"1997","journal-title":"Methods Enzymol."},{"key":"2024020318430938100_bib19","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"National Research Council","year":"2011"},{"issue":"1","key":"2024020318430938100_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2024020318430938100_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00467-010-1717-5","article-title":"New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome","volume":"26","author":"van Husen","year":"2011","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"2024020318430938100_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.109.1.45","article-title":"Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version","volume":"109","author":"Ogden","year":"2002","journal-title":"Pediatrics."},{"issue":"4","key":"2024020318430938100_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jpeds.2008.04.028","article-title":"Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease","volume":"153","author":"Tuchman","year":"2008","journal-title":"J Pediatr."},{"issue":"1","key":"2024020318430938100_bib24","first-page":"45","article-title":"The LMS method for constructing normalized growth standards","volume":"44","author":"Cole","year":"1990","journal-title":"Eur J Clin Nutr."},{"key":"2024020318430938100_bib25","volume-title":"LMS Chartmaker Pro","author":"Cole","year":"2006"},{"issue":"10","key":"2024020318430938100_bib26","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2024020318430938100_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.0006-341X.2002.00521.x","article-title":"Use of quasi-least squares to adjust for two levels of correlation","volume":"58","author":"Shults","year":"2002","journal-title":"Biometrics."},{"key":"2024020318430938100_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1536867X0700700201","article-title":"Improved generalized estimating equation analysis via xtqls for quasi-least squares in Stata","volume":"7","author":"Shults","year":"2007","journal-title":"Stata J."},{"issue":"10","key":"2024020318430938100_bib29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: mechanisms and clinical implications","volume":"123","author":"Mazziotti","year":"2010","journal-title":"Am J Med."},{"key":"2024020318430938100_bib30","first-page":"731","volume-title":"Pediatric nephrology","author":"Clark","year":"1999","edition":"4th ed"},{"issue":"4","key":"2024020318430938100_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1359\/jbmr.070110","article-title":"Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn disease or nephrotic syndrome: impact of the underlying disease","volume":"22","author":"Burnham","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020318430938100_bib32","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ajcn\/80.5.1334","article-title":"Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids","volume":"80","author":"Foster","year":"2004","journal-title":"Am J Clin Nutr."},{"issue":"3","key":"2024020318430938100_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bone.2007.04.197","article-title":"Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys","volume":"41","author":"Fox","year":"2007","journal-title":"Bone."},{"issue":"1","key":"2024020318430938100_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1359\/jbmr.2001.16.1.157","article-title":"Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys","volume":"16","author":"Burr","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024020318430938100_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1359\/jbmr.2001.16.1.97","article-title":"Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis","volume":"16","author":"Dalle Carbonare","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2024020318430938100_bib36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1096\/fj.01-0640fje","article-title":"Recovery from osteoporosis through skeletal growth: early bone mass acquisition has little effect on adult bone density","volume":"16","author":"Gafni","year":"2002","journal-title":"FASEB J."},{"issue":"3","key":"2024020318430938100_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00467-005-2118-z","article-title":"Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome","volume":"21","author":"Bak","year":"2006","journal-title":"Pediatr Nephrol."},{"issue":"8","key":"2024020318430938100_bib38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/ndt\/gfh809","article-title":"Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements","volume":"20","author":"Gulati","year":"2005","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"2024020318430938100_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF02254183","article-title":"Vitamin D metabolites in childhood nephrotic syndrome","volume":"9","author":"Grymonprez","year":"1995","journal-title":"Pediatr Nephrol."},{"issue":"7","key":"2024020318430938100_bib40","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jbmr.387","article-title":"Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship","volume":"26","author":"Powe","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020318430938100_bib41","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1523-1755.2005.00690.x","article-title":"Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome","volume":"68","author":"Hegarty","year":"2005","journal-title":"Kidney Int."},{"issue":"6","key":"2024020318430938100_bib42","first-page":"705","article-title":"[Evaluation of bone mineral turnover in children with nephrotic syndrome\u2014the implications of original disease and the effects of corticosteroids on bone metabolism.]","volume":"35","author":"Takeda","year":"1993","journal-title":"Nihon Jinzo Gakkai Shi."},{"issue":"6","key":"2024020318430938100_bib43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/BF00869084","article-title":"Influence of steroid medication on bone mineral density in children with nephrotic syndrome","volume":"8","author":"Lettgen","year":"1994","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"2024020318430938100_bib44","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s004670050308","article-title":"A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome","volume":"11","author":"Broyer","year":"1997","journal-title":"Pediatr Nephrol."},{"issue":"2","key":"2024020318430938100_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00198-011-1621-2","article-title":"Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome","volume":"23","author":"Feber","year":"2012","journal-title":"Osteoporos Int."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1785","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/3\/480\/56564402\/1785_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/3\/480\/56564402\/1785_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:48:01Z","timestamp":1710341281000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/28\/3\/480-488\/7598778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,8]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,10,8]]},"published-print":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1785","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,3,1]]},"published":{"date-parts":[[2012,10,8]]}}}